Analysis

Ardelyx, Inc. (ARDX) Stock Analysis

Ardelyx, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to ARDX.

websiteARDX/analysis/ARDX

Ardelyx, Inc.

Ardelyx, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to ARDX.

Stock profile

Ticker

ARDX

Asset type

Stock

Market cap

$1.49B

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Ardelyx, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • ARDX primary listing
  • 41X
  • A116X0

Latest Ardelyx, Inc. news

Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026

WALTHAM, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on the developmen...

Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings

WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of i...

Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update

Q1 2026 total product revenue of $93.4 million, reflecting 38% growth year-over-year IBSRELA Q1 2026 revenue growth of 58% year-over-year to $70.1 million; Reiterating guidance ...

Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings

Presentation evaluates the long-term impact of XPHOZAH® on serum electrolytes and select nutrition biomarkersWALTHAM, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Na...

Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026

WALTHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of...

Research sections

Valuation

Review valuation context for Ardelyx, Inc..

Future growth

Review future growth context for Ardelyx, Inc..

Past performance

Review past performance context for Ardelyx, Inc..

Financial health

Review financial health context for Ardelyx, Inc..

Dividend

Review dividend context for Ardelyx, Inc..

Management

Review management context for Ardelyx, Inc..

Ownership

Review ownership context for Ardelyx, Inc..

Other information

Review other information context for Ardelyx, Inc..

Community

Review community context for Ardelyx, Inc..